PhD Urška Kamenšek

PhD Urška Kamenšek
no.: 28387 source: ARIS

researcher – active in research organisation
  ukamensekat signonko-i.si
Edit
Research activity

Code Science Field Subfield
3.04.00  Medical sciences  Oncology   
3.01.00  Medical sciences  Microbiology and immunology   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
858.16
A''
128.23
A'
438.39
A1/2
494.87
CI10
573
CImax
82
h10
13
A1
3
A3
4.5
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2019, 2020, 2021, 2022, 2023)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 64  949  532  8.31 
Scopus 57  1,045  623  10.93 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Tinkara Remic   Bologna doctoral studies  10/1/2017 - 9/30/2022  50593 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Biotechnical Faculty 2005 
Doctoral degree  Ph. D.     SI University of Ljubljana, Faculty of Medicine 2010 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:100%)  Institute of Oncology Ljubljana  Department of research  11/1/2006  Analyst  Researcher   
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-60068  Circulating tumor cell translational research platform.   1/1/2025 - 12/31/2027  PhD Tanja Jesenko   2,923 
2. J1-60017  Perfusion, Edema, and Necrosis Evaluation using OCT for Tumor Outcome Measures   1/1/2025 - 12/31/2027  PhD Jošt Stergar   2,743 
3. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   10/1/2023 - 9/30/2026  PhD Katarina Žnidar   2,397 
4. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   10/1/2023 - 9/30/2026  PhD Maja Čemažar   3,048 
5. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   10/1/2023 - 9/30/2026  PhD Katja Uršič Valentinuzzi   3,367 
6. J2-50068  Safety and efficacy of high frequency electrochemotherapy - clinical device development   10/1/2023 - 9/30/2026  PhD Matej Reberšek   3,729 
7. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   10/1/2022 - 9/30/2026  PhD Lucija Peterlin Mašič   6,640 
8. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   10/1/2022 - 9/30/2025  PhD Igor Muševič   5,928 
9. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   10/1/2021 - 9/30/2025  PhD Gregor Serša   7,319 
10. J3-9269  Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in patients undergoing electrochemotherapy   7/1/2018 - 6/30/2021  PhD Gregor Serša   3,831 
11. J3-8202  Spremljanje imunskega odziva v realnem času po in situ vakcinaciji z elektrokemoterapijo in pridruženo gensko terapijo z interlevkinom-12 (Slovene)   5/1/2017 - 4/30/2020  PhD Maja Čemažar   3,811 
12. J1-6730  Razvoj novih celičnih linij človeških jeter za raziskave genotoksičnosti in karcinogenosti: novo upanje za človekovo zdravje in zaščito laboratorijskih živali (Slovene)   11/1/2014 - 10/31/2017  PhD Metka Filipič   4,374 
13. J3-6793  Novi pristopi radiosenzibilizacije tumorjev z gensko terapijo (Slovene)   7/1/2014 - 6/30/2017  PhD Gregor Serša   5,483 
14. J3-6796  Translacijska onkologija: razvoj in validacija imunsko genske terapije z interleukinom-12 v kombinaciji s kirurgijo pri oralnih in kožnih tumorjih psov (Slovene)   7/1/2014 - 6/30/2017  PhD Maja Čemažar   5,190 
15. J3-5505  Elektrokemoterapija globoko ležečih tumorjev (Slovene)   8/1/2013 - 7/31/2016  PhD Gregor Serša   4,555 
16. J3-4211  Antiangiogena genska terapija raka: tarčno zdravljenje z uporabo elektroporacije in magnetnih nanodelcev kot dostavnih sistemov (Slovene)   7/1/2011 - 6/30/2014  PhD Gregor Serša   6,891 
17. J1-4044  Apoptotično delovanje alkilpiridinijevih spojin na celice pljučnega adenokarcinoma (Slovene)   7/1/2011 - 6/30/2014  PhD Tom Turk   6,673 
18. J3-4259  Priprava in validacija terapevtskih plazmidov brez selekcijskega gena za antibiotično rezistenco za gensko terapijo raka z inducibilnimi in tkivno specifičnimi promotorji (Slovene)   7/1/2011 - 6/30/2014  PhD Maja Čemažar   6,296 
19. J1-4131  Sinteza, karakterizacija in uporaba novih rutenijevih spojin v elektrokemoterapiji tumorjev (Slovene)   7/1/2011 - 6/30/2014  PhD Iztok Turel   6,384 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2022 - 12/31/2027 PhD Gregor Serša   4,393 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2015 - 12/31/2021 PhD Gregor Serša   3,528 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2009 - 12/31/2014 PhD Gregor Serša   4,296 
Confirmation required
Views history
Favourite